StockData
Neurogene Inc. logo

Neurogene Inc. (NGNE) stock

NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$23.10−0.20 (-0.86%)

Close on Nov 17, 2026Market cap $462.26MP/E –Yield –

Neurogene price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Neurogene's price to book ratio was 1.8× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.6× to 14.4×, with a median of 2.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.8×+0.7
2025Dec 31, 20251.1×−1.0
2024Dec 31, 20242.2×+1.2
2023Jan 31, 20231.0×+0.1
2022Dec 30, 20220.8×−4.5
2021Dec 31, 20215.3×−6.5
2020Dec 31, 202011.8×−8.9
2019Dec 31, 201920.7×+18.1
2018Dec 31, 20182.7×−7.0
2017Dec 29, 20179.7×−0.3
2016Dec 30, 201610.0×+2.4
2015Dec 31, 20157.5×+3.3
2014Dec 31, 20144.2×–

More Neurogene figures

See a number that looks wrong?